The FDA's rejection of fluvoxamine as a Covid drug, explained
The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.
Source: vox.com
Page 12 - Eric Lenze News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Lenze. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Lenze Today - Breaking & Trending Today
Coronavirus drugs face long trials, challenges before they hit market
Scientists are testing existing drugs for their effects on COVID-19, but there's still a long road before they can be used to treat the virus.
Source: greatfallstribune.com
Why cheap, older drugs that might treat COVID never get out of the lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Source: usf.edu
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
In March 2020, Dr. Joseph Vinetz left the contemplative world of his Yale University infectious-disease laboratory and plunged into the covid ward at Yale New Haven Hospital, joining an army of health care workers who struggled to treat the deadly viral disease. There were no drugs against covid-19, and no way to predict which infected […]
Source: physiciansweekly.com
Why cheap, older drugs that might treat COVID never get out of the lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Source: usf.edu